Travoprost on Curative Effect in Patients with Poorly Controlled IOP after Complex Trabeculectomy Surgery

CHENG Dao-an; CHEN Yao-ruo; YE Xiao-ling

Abstract：Objective:To observation of Travoprost therapy for patients with poor IOP control after trabeculectomy.Method:In the 13 cases of patients with glaucoma intraocular pressure bad control hospital compound trabeculectomy,the postoperative intraocular pressure control data were retrospectively analyzed, in 13 patients with intraocular pressure in the eye drop control winding forefront,if patients remain poorly controlled,the combined use of Brinzolamide Eye Drops control intraocular pressure,comparison and analysis of these 13 patients before treatment and after first,3,6,12 months,visual acuity,intraocular pressure, vision cup disc ratio and OCT optic nerve fiber thickness variation. Result:9 cases in the Travoprost Eye Drops IOP after treatment as well as the diurnal intraocular pressure difference control in the normal range,the effective rate of treatment was 69.2%;in the visual field defect in 13 cases,visual field defect patients showed no deterioration;during follow-up 13 patients vision without falling,without increasing the cup to disc ratio,the optic nerve fiber without further thinning medication period,no adverse reactions were seen in 1 patients and drug related. Conclusion:The compound trabeculectomy intraocular pressure IOP in patients with poorly controlled within 30 mm Hg,the IOP hormone eye drops in the forefront of control,intraocular pressure can be controlled in 16-18 mm Hg of the safe range,to avoid further damage of visual function,protect patients visual acuity.